Product Details
NovoSeven 2 mg (100 KIU) powder and solvent for solution for injection
Coagulation factor VIIa2 mg (100 KIU)/Vial
Powder for solution for injection/infusion
ROA
Intravenous
Applicant Name
Novo Nordisk Pharma Ltd
NRN
A6-0566
Status
Active
Composition
Each vial contains: Activated recombinant coagulation factor VIIa (eptacog alfa) 2 mg (corresponds to 100 KIU). 1 KIU equals 1,000 IU (International Units). Eptacog alfa (activated) is recombinant coagulation factor VIIa (rFVIIa) with a molecular mass of approximately 50,000 Daltons produced in baby hamster kidney cells (BHK Cells) by recombinant DNA technology. After reconstitution, the product contains 1 mg/mL eptacog alfa (activated) when reconstituted with solvent
ATC Code/ATCvet Code
B02BD08
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
2 mg (100 KIU) x 1's (in clear glass vial) + 2 mL Histidine solvent (in clear glass pre-filled syringe)
Product Description
Powder and solvent for solution for injection. White lyophilised powder. Solvent: clear colourless solution. The reconstituted solution has a pH of approximately 6.0.
Manufacturer Name
Novo Nordisk A/S
Manufacturer Country
DENMARK
Approval Date
2019-10-31
Expiry Date
2024-10-30